<DOC>
	<DOCNO>NCT02868177</DOCNO>
	<brief_summary>Given data active ingredient Totum-63 , research aim evaluate effect chronic consumption ( 24 week ) glucose lipid homeostasis especially fast plasma glucose volunteer abdominal obesity associate impaired glucose tolerance untreated type 2 diabetes hypertriglyceridemia . This clinical study design estimate effect Totum-63 , active ingredient Valedia , several glucose lipid homeostasis relate parameter since data still unknown specific dietary supplement formula . Collected data provide reliable information may use plan subsequent large main study .</brief_summary>
	<brief_title>Effect Totum-63 , Active Ingredient Valedia , Glucose Lipid Homeostasis Subjects With Prediabetes</brief_title>
	<detailed_description>Primary objective : The primary objective present trial ass beneficial effect Totum-63 compare placebo glucose homeostasis assess fast plasma glucose level prediabetics untreated type 2 diabetic 24 week consumption . Secondary objective : Secondary objective study assess efficacy Totum-63 compare placebo prediabetics untreated type 2 diabetic 12 24 week consumption follow criterion : - Glucose homeostasis assess fast plasma glucose level ( 12 week consumption ) , fast blood HbA1c fructosamine level , OGTT ( Oral Glucose Tolerance Test 24 week consumption ) , insulinemic glycemic parameter . - Pancreatic beta-cells function insulin sensitivity assess fast blood insulin level , HOMA-IR ( Homeostasis Model Assessment Insulin Resistance ) , HOMA-β , QUICKI ( Quantitative Insulin sensitivity Check Index ) ISI-M ( Matsuda-DeFronzo Insulin Sensitivity Index 24 week consumption ) index . - Lipid homeostasis assess fast blood level triglyceride ( TG ) , Total Cholesterol ( TC ) , HDL-cholesterol , LDL-cholesterol NEFA ( Non-Esterified Fatty Acids ) . - Oxidation mechanism circulate lipid assess ratio fast blood LDLox / fast blood LDLc PON-1 ( paraoxonase-1 , arylesterase activity ) activity blood . - Low grade inflammation assess fast blood hsCRP level . - Hepatic function assess fast blood total bilirubin level , GGT , ASAT ALAT activity blood . - Hemodynamics assessed Heart Rate ( HR ) , Systolic Blood Pressure ( SBP ) , Diastolic Blood Pressure ( DBP ) . - Anthropometrics assess Body Weight ( BW ) , Waist Circumference ( WC ) , Hip Circumference ( HC ) Waist Hip Ratio ( WHR ) . - Satiety assess three-day food diary energy nutrient intake parameter . Safety objectives : The follow criterion assess 24 week study product consumption participate objective safety check : - Renal function assess fast blood creatinine urea level ; - Complete blood count .</detailed_description>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>I1 . Fasting glycemia &gt; 6,1 mmol/L . ( 1,1 g/L ) . I2 . 2 hour glycemia ( OGTT ) &gt; 7,8 mmol/L ( 1,4 g/L ) . I3 . HbA1c &lt; 7 % I4 . Triglyceridemia &gt; 1,5 g/L . I5 . Prediabetic type2 diabetic require immediate drug therapy accord current recommendation ( HAS , 2013 ) . I6 . Waist circumference &gt; 94 cm men &gt; 80 cm woman . I7 . With report body weight variation &lt; 5 % 3 month prior randomization . I8 . Without significant change food habit physical activity 3 month randomization agree keep unchanged throughout study ( hyperhypocaloric diet startstop sport activity plan next 7 month ) . I9 . For woman : Non menopausal reliable contraception since least three month begin study agree keep entire duration study ( hormonal contraception , intra uterine device surgical intervention ) menopausal without hormone replacement therapy ( oestrogenic replacement therapy begin less 3 month exclude ) . I10 . Good general mental health opinion investigator : clinically significant relevant abnormality medical history physical examination . I11 . Able willing participate study comply protocol procedure evidence dated sign informed consent form . I12 . Affiliated social security scheme . I13 . Agree register volunteer biomedical research file . E1 . Fasting blood triglyceride &gt; 3,5 g/L . E2 . TSH outside laboratory normal value . E3 . Fasting blood TC &gt; 4,5 g/L HDLc &lt; 0,1 g/L abnormality judge clinically significant accord investigator . E4 . Blood AST , ALT GGT &gt; 3xULN ( laboratory Upper Limit Normal ) . E5 . Blood urea &gt; 12 mmol/L creatinine &gt; 125 µmol/L . E6 . Complete blood count hemoglobin &lt; 11 g/L leucocyte &lt; 3000 / mm3 leucocytes &gt; 16000 / mm3 clinically significant abnormality accord investigator . E7 . Suffering metabolic disorder treat diabetes , uncontrolled thyroidal trouble metabolic disorder . E8 . Suffering uncontrolled hypertension ( systolic blood pressure ≥ 160 mmHg and/or diastolic blood pressure ≥ 100 mmHg ) . E9 . With history retinopathy , microalbuminuria , ischemic cardiovascular event , previous 6 month surgical procedure . E10 . Suffering severe chronic disease ( e.g . cancer , HIV , renal failure , hepatic biliary disorder ongoing , chronic inflammatory digestive disease , arthritis chronic respiratory trouble , etc . ) gastrointestinal disorder find inconsistent conduct study investigator ( e.g . celiac disease ) . E11 . Under antidiabetic drug ( e.g . biguanides , sulfonylurea , glinides , gliptines , glitazones , gliflozines , αglucosidase inhibitor , incretins insulin ) . E12 . Under lipidlowering treatment ( e.g . statin , fibrates , ezetimibe , bile acid sequestrants , niacin , etc . ) stop less 3 month randomization . E13 . Requiring cholesterol lower immediate pharmacologic intervention accord current recommendation ( AFSSAPS 2005 ) . E14 . Under medication could affect glucose and/or lipid homeostasis parameter stop less 3 month randomization ( e.g . beta 2 agoniste like salbutamol , Angiotensin Converting Enzyme ( ACE ) inhibitor , beta blocker , thiazide diuretic , Selective Serotonin Reuptake Inhibitors ( SSRIs ) , MonoAmine Oxidase Inhibitors ( MAOIs ) , neuroleptic , longterm corticosteroid systemic drug , systemic antibody , androgen , phenytoin , interferon , immunosuppressant , antiviral antiretrovirals , etc. ) . Beta 2 agoniste like salbutamol , ACE inhibitor , beta blocker , thiazide diuretic , SSIRs , MAOIs begin 3 month randomization maintain stable whole study tolerate . The others drug ( neuroleptic , longterm corticosteroid systemic drug , systemic antibody , androgen , phenytoin , interferon , immunosuppressant , antiviral antiretrovirals , etc . ) allow study . E15 . Regular intake dietary supplement `` health food '' rich plant stanol sterol ( like PROACTIV DANACOL product ) , long chain omega3 fatty acid ( especially sofgels contain fish oil ) , substance intend low LDLc , TG glycemia ( e.g . betaglucans , konjac , cinnamon , olive leaf extract , berberine , red yeast rice , policosanol , etc . ) stop less 3 month randomization . E16 . Under treatment dietary supplement could significantly affect parameter ( ) follow study accord investigator stop short period randomization . E17 . Under dietary supplement month V1 . E18 . With know suspect food allergy intolerance hypersensitivity study product ' ingredient . E19 . Consuming 3 standard drink alcoholic beverage men 2 standard drink daily woman agree keep alcohol consumption habit unchanged throughout study . E20 . With extreme eat habit ( e.g . vegetarian vegan ) . E21 . With personal history anorexia nervosa , bulimia significant eating disorder accord investigator . E22 . Smoking 10 cigarette daily agree keep smoking habit unchanged throughout study . E23 . Having lifestyle deem incompatible study accord investigator include high level physical activity ( define 10 hour significant physical activity week , walk exclude ) . E24 . Pregnant lactate woman intend become pregnant within 7 month ahead . E25 . Who make blood donation 3 month randomization intend make within 7 month ahead . E26 . Taking part another clinical trial exclusion period previous clinical trial . E27 . Having receive , last 12 month , indemnity clinical trial high equal 4500 Euros . E28 . Under legal protection ( guardianship , wardship ) deprive right follow administrative judicial decision . E29 . Presenting psychological linguistic incapability sign inform consent . E30 . Impossible contact case emergency .</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Prevention</keyword>
</DOC>